Invest with AccretivUSA Review
Summary
The website promotes a real estate investment opportunity with a minimum investment of $100.
It claims to offer an 8% APY return, but returns are not distributed until a liquidity event or withdrawal.
The investment is subject to substantial risks, including illiquidity and potential loss of principal.
The company provides an offering circular filed with the SEC, which adds some legitimacy.
The website lacks detailed information about the team, past performance, or specific properties.
The investment involves a minimum holding period of 4 years, with penalties for early withdrawal.
Detailed Analysis
Overview
The website belongs to AccretivUSA, a company offering a medical real estate investment fund under Regulation A+. The fund allows both accredited and non-accredited investors to participate with a minimum investment of $100. The company promises an 8% APY return, though returns are not distributed until a liquidity event or withdrawal.
Trust Factors
The website provides a link to the SEC's EDGAR database for the offering circular, which is a positive sign of regulatory compliance. The involvement of Dalmore Group, LLC, a registered broker-dealer, adds credibility. However, the website lacks detailed information about the team, specific properties, or past performance, which could raise concerns.
Red Flags
The investment is highly illiquid, with a minimum holding period of 4 years and penalties for early withdrawal. The 8% APY return is not guaranteed and is subject to the company's financial performance. The website's emphasis on 'small steps' and low minimum investment could be seen as targeting inexperienced investors.
Conclusion
While the website appears to comply with regulatory requirements, the investment carries significant risks. Potential investors should thoroughly review the offering circular, consult a financial advisor, and consider the illiquidity and potential loss of principal before investing.
Your Experience